Edinburgh, United Kingdom
AlgiSys BioSciences, Inc., founded in 2009 and headquartered in the United States, is making a significant impact in the Biotechnology and Pharmaceutical industries with its strong focus on Clean Energy principles. The company is committed to the Environmental, Social, and Corporate Governance (E,S,G) framework, aiming to preserve natural resources while maintaining transparency and social responsibility.
Operating under the slogan "OMEGA-3 EPA and PLANT PROTEIN Directly From ALGAE. Eco-Friendly ● Sustainable ● Cost Effective.", AlgiSys offers a groundbreaking alternative to traditional fish sources in the lucrative $57 billion Omega-3 industry. Its patented algal technology provides a sustainable and eco-friendly substitute for fish oil, supplying high-quality omega-3 EPA across multiple sectors, including supplements, cosmetics, and pharmaceuticals.
With proven cost-effective production methods, AlgiSys received a $6.15M Series A investment on 14 August 2013. The firm's innovative approach positions it well to address environmental concerns while meeting rising industry demands.
